- Live video webcast on Tuesday, August 19th at 2:40 PM ET HOUSTON, TX / ACCESS Newswire / August 14, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025 Details for the presentation are as follows: Date and Time: Tuesday, August 19, 2025 at 2:40 PM ET Presenter: John Climaco, Chief Executive Officer Registration Link: HERE …

BOSTON and LONDON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing novel Antibody Drug Conjugates (ADCs) with immuno-oncology payloads for the treatment of cancer, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Tuesday, August 19, 2025 at 2:00 PM ET Presenter: Abizer Gaslightwala, President and Chief Executive Officer of Akari Registration Link: HERE About Webull Financial Webull Financial is a leading online brokerage platform committed to empowering self-directed investors with …

– Live video webcast on Wednesday, August 20 th at 2:00 PM ET HOUSTON, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses, today announced that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details of the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:00 PM ET Presenter: Walter Klemp, Founder, President, CEO and Chairman of Moleculin Registration Link: HERE About Webull Financial …

Boca Raton, Florida--(Newsfile Corp. - August 14, 2025) - Entero Therapeutics, Inc. (NASDAQ: ENTO) (the "Company"), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced that, it will effect a 1 for 3 reverse stock split of its common stock. The Company expects its common stock to begin trading on a split-adjusted basis on the Nasdaq Capital Market as of the commencement of trading on August 18, 2025.

Humana Walking Club will foster community engagement at Simon centers across the country and encourage healthier lifestyles INDIANAPOLIS , Aug. 14, 2025 /PRNewswire/ -- Simon ®, a real estate investment trust engaged in the ownership of premier shopping, dining, entertainment and mixed-use destinations, today announced a new initiative with health and well-being company Humana to enable health, inspire physical activity and foster connectivity. Working in collaboration with Simon Media & Experiences, the company's media division, Humana will implement a multi-faceted program at 21 Simon centers across the country to invite community members to get moving and get healthy with the …

PEMBROKE, Bermuda--(BUSINESS WIRE)---- $AXS #insurance--AXIS Capital Holdings Limited (“AXIS Capital” or “AXIS” or the “Company”) (NYSE: AXS) today announced that Matthew Kirk will be appointed as the Company's next Chief Financial Officer effective March 2026, as part of a planned leadership transition. He will succeed Peter J. Vogt, who at that time, will act as a strategic advisor to the Company through the end of 2026 to support a smooth transition. Mr. Kirk, who presently serves as Chief Financial Officer of.

MCLEAN, Va.--(BUSINESS WIRE)--BigBear.ai (NYSE: BBAI), a leader in mission-ready AI for national security, today announced the successful integration of its Pangiam® Threat Detection solution with Smiths Detection's HI-SCAN 6040 CTiX computed tomography screening systems. This integration – now available for airports worldwide – delivers real-time detection of prohibited items in luggage, enhancing security operations across aviation, port, and border environments. The integrated solution compl.

Live video webcast on Wednesday, August 20 th at 2:20 PM ET LA JOLLA, CA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, that it will present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech being held virtually August 19-21, 2025. Details for the presentation are as follows: Date and Time: Wednesday, August 20, 2025 at 2:20 PM ET Presenter: Marc Hertz, PhD, President, Chief Executive Officer and …

The three major indices in the US are all looking to be somewhat choppy at this point in time. The US stock market continues to see a lot of problems with volume, as this time of year is typically very low with traders on holiday.

Ulta Beauty and Target on Thursday said they have mutually agreed to end their partnership in 2026.

NGG's strong earnings outlook, $69B investment plan and 5.77% dividend yield make it a standout in the utility sector.

MediWound (MDWD) came out with a quarterly loss of $1.23 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to a loss of $0.68 per share a year ago.

I remain bullish on Kyndryl, driven by its HPE alliance and focus on accelerating private cloud and AI adoption. Despite recent revenue softness, the company's shift to high-margin contracts and hyperscaler partnerships is fueling improved profitability and future growth. Hyperscaler-related revenues surged 86% YoY, and operational efficiency is driving a significant EPS increase, supporting my positive outlook.

IFS delivered strong Q2 results, with a net profit of S/580 million and ROE of 20.7%. Peru's macroeconomic outlook remains positive, and we believe IFS will not be materially affected by the April 2026 election. Our investment thesis has a new upside related to its dividend policy. IFS might also enhance shareholder returns via buyback.

The smart money (hedge fund managers) have been making some notable, although perhaps less surprising moves in recent quarters.

FREMONT, Calif. & CLEARWATER, Fla.--(BUSINESS WIRE)--TD SYNNEX published its Corporate Citizenship Report, highlighting momentum across the company's environmental, social and governance priorities.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Hims between April 29, 2025 and June 22, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Hims & Hers Health, Inc. ("Hims" …

Many assume we know who's who in AI: Nvidia, Microsoft, Alphabet, etc. Not so! Many are missing out on consultants that help companies implement AI. Cognizant Technology Solutions Corporation is one such consultant. It's not the biggest. But the path it traveled that led it to AI consulting gives it some unique advantages and perspectives. With roots in Business Process Outsourcing, CTSH has developed serious “domain knowledge” in particular industries. If you ever hired a consultant, you KNOW how valuable that is.

CRM's Data Cloud, storing 22T data points and growing ARR by 120% in Q1, is becoming central to its AI-driven growth push.

Opendoor's August surge is driven by meme-stock buzz, big-name investor backing and fresh corporate shake-up talk.